North America Blood Collection Tubes for Liquid Biopsy Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (ccfDNA Tubes, cfRNA Tubes, CTC Tubes, gDNA Tubes, Intracellular RNA Tubes, and Others), Material (Glass and Plastic), Application (In-Vitro Diagnostics (IVD) and Research), and End User (Genetic Diagnostic Labs, R&D Centres, Conventional Diagnostic Centres, and Others)
The North America blood collection tubes for liquid biopsy market is expected to reach US$ 11.81 thousand by 2028 from US$ 35.80 thousand in 2021; it is estimated to grow at a CAGR of 18.6% from 2021-2028.
The growth of the market is due to increasing prevalence of cancer worldwide and rising demand for minimally invasive diagnostic tests. However, lack of skilled professionals leading to inaccurate blood collection tubes for liquid biopsy analysis is expected to restrict the market growth during the forecast period.
Health systems globally are witnessing a substantial increase in the prevalence of cancer. According to the World Health Organization, cancer is the second-leading cause of mortality worldwide. According to the International Agency for Research on Cancer (IARC), the global cancer burden has increased to 19.3 million cases and 9.96 million cancer deaths by 2020. According to the data published by the World Health Organization (WHO), in 2019, around 9.6 million deaths were caused by cancer globally. Moreover, according to the same data, prostate, lung, colorectal, liver, and stomach cancer are most observed in men, while breast, colorectal, and cervical cancer are the most common among women.
Furthermore, according to a study published by the National Cancer Institute, in 2021, the incidence of cancer in the US likely reached 1.9 million. In addition, around 0.6 million people were anticipated to die in 2021 in the US due to cancer.
Liquid biopsies are used for diagnosing non–small cell lung cancer (NSCLC) and screening or as a companion diagnostic for other types of cancers such as colorectal, breast, gastrointestinal, prostate, and ovarian. Early prognosis, reduced cost, therapy monitoring, acquired drug resistance, detection of tumor heterogeneity, and patient comfort are benefits of liquid biopsy over traditional cancer diagnostics approaches (by eliminating the need for surgery). As a result, the preference for liquid biopsy increases parallelly with the rise in cancer prevalence. As a result, blood collection tubes for liquid biopsy contribute to the organization's strategy to detect cancer early and precisely, allowing for quick treatment and enhancing cancer patients' survival rates, thereby boosting the growth of the North America blood collection tubes for liquid biopsy market. The factors mentioned above boost the growth of the North America blood collection tubes for liquid biopsy market.
The North America had been adversely affected by the COVID-19 pandemic like other regions. However, recent spikes in cases and hospitalizations suggest that pressure will become more widespread in the coming months, with less resiliency across the country to support surges in care demand. To manage demand early in the pandemic, some clinicians relied on resources from other parts of the country, such as supplies, and postponed "elective" care to free up resources for COVID-19 patients. The region of the Americas has now surpassed 100 million cases of COVID-19, latest Pan American Health Organization (PAHO) epidemiological data show, with the US driving a 36% increase in cases in North America in the second week of December and parts of Central and South America reporting declines.
The COVID-19 pandemic negatively impacted the people suffering from cancer and cancer surveillance capacities. Reduced resources and availability to care as a result of the pandemic made cancer detection and treatment more difficult, resulting in lower incidence, higher mortality, and lower survival in the future. People with active cancer are more susceptible to infectious pathogens due to compromised immune systems caused by cancer or its treatment, including surgery and chemotherapy. This raised fears that COVID-19 problems and mortality may be more common in cancer patients.
North America Blood Collection Tubes for Liquid Biopsy Market Revenue and Forecast to 2028 (US$ Mn)
Get more information on this report :
NORTH AMERICA BLOOD COLLECTION TUBES FOR LIQUID BIOPSY MARKET SEGMENTATION
By Product
- ccfDNA Tubes
- cfRNA Tubes
- CTC Tubes
- gDNA Tubes
- Intracellular RNA Tubes
- Others
By Material
- Plastic
- Glass
By Application
- In-Vitro Diagnostics (IVD)
- Research
By End User
- Genetic Diagnostic Labs
- R&D Centres
- Conventional Diagnostic Centres
- Others
By Country
- US
- Canada
- Mexico
Company Profiles
- PreAnalytiX GmbH
- Biocept, Inc.
- F. HOFFMANN-LA ROCHE LTD.
- STRECK
- Norgen Biotek Corp
- Exact Sciences Corporation
- Greiner AG
- MagBio Genomics, Inc
- Zymo Research Corporation
- Apostle Sciences
1. Introduction
1.1 Study Scope
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 North America Blood Collection Tubes for Liquid Biopsy Market – By Product
1.3.2 North America Blood Collection Tubes for Liquid Biopsy Market – By Material
1.3.3 North America Blood Collection Tubes for Liquid Biopsy Market – By Application
1.3.4 North America Blood Collection Tubes for Liquid Biopsy Market – By End User
1.3.5 North America Blood Collection Tubes for Liquid Biopsy Market – By Country
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Blood Collection Tubes for Liquid Biopsy Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America PEST Analysis
4.3 Experts Opinion
5. Blood Collection Tubes for Liquid Biopsy Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Increase in Prevalence of Cancer Worldwide
5.1.2 Rise in Demand for Minimally Invasive Diagnostic Tests
5.2 Market Restraints
5.2.1 Lack of Skilled Professionals Leading to Inaccurate Blood Collection for Liquid Biopsy Analysis
5.3 Future Trends
5.3.1 Technological Advancements in Blood Collection Tubes for Liquid Biopsy
5.4 Impact Analysis
6. Blood Collection Tubes for Liquid Biopsy Market–North America Analysis
6.1 North America Blood Collection Tubes for Liquid Biopsy Market Revenue Forecast and Analysis
7. North America Blood Collection Tubes for Liquid Biopsy Market Revenue and Forecasts To 2028– by Product
7.1 Overview
7.2 Blood Collection Tubes for Liquid Biopsy Market, By Product, 2021 & 2028 (%)
7.3 ccfDNA Tubes
7.3.1 Overview
7.3.2 ccfDNA Tubes: Blood Collection Tubes for Liquid Biopsy Market Revenue and Forecasts to 2028 (US$ ‘000)
7.4 cfRNA Tubes
7.4.1 Overview
7.4.2 cfRNA Tubes: Blood Collection Tubes for Liquid Biopsy Market Revenue and Forecasts to 2028 (US$ ‘000)
7.5 CTC Tubes
7.5.1 Overview
7.5.2 CTC Tubes: Blood Collection Tubes for Liquid Biopsy Market Revenue and Forecasts to 2028 (US$ ‘000)
7.6 gDNA Tubes
7.6.1 Overview
7.6.2 gDNA Tubes: Blood Collection Tubes for Liquid Biopsy Market Revenue and Forecasts to 2028 (US$ ‘000)
7.7 Intracellular RNA Tubes
7.7.1 Overview
7.7.2 Intracellular RNA Tubes: Blood Collection Tubes for Liquid Biopsy Market Revenue and Forecasts to 2028 (US$ ‘000)
7.8 Others
7.8.1 Overview
7.8.2 Others: Blood Collection Tubes for Liquid Biopsy Market Revenue and Forecasts to 2028 (US$ ‘000)
8. Blood Collection Tubes for Liquid Biopsy Market Revenue and Forecasts To 2028 – by Material
8.1 Overview
8.2 Blood Collection Tubes for Liquid Biopsy Market Share by Material - 2021 & 2028 (%)
8.3 Plastic
8.3.1 Overview
8.3.2 Plastic: Blood Collection Tubes for Liquid Biopsy Market Revenue and Forecast to 2028 (US$ ‘000)
8.4 Glass
8.4.1 Overview
8.4.2 Glass: Blood Collection Tubes for Liquid Biopsy Market Revenue and Forecast to 2028 (US$ ‘000)
9. Blood Collection Tubes for Liquid Biopsy Market Revenue and Forecasts To 2028 – by Application
9.1 Overview
9.2 Blood Collection Tubes for Liquid Biopsy Market Share by Application - 2021 & 2028 (%)
9.3 In-Vitro Diagnostics (IVD)
9.3.1 Overview
9.3.2 In-Vitro Diagnostics (IVD): Blood Collection Tubes for Liquid Biopsy Market Revenue and Forecast to 2028 (US$ ‘000)
9.4 Research
9.4.1 Overview
9.4.2 Research: Blood Collection Tubes for Liquid Biopsy Market Revenue and Forecast to 2028 (US$ ‘000)
10. Blood Collection Tubes for Liquid Biopsy Market Revenue and Forecasts To 2028 – by End-User
10.1 Overview
10.2 Blood Collection Tubes for Liquid Biopsy Market Share by End User - 2021 & 2028 (%)
10.3 Genetic Diagnostic Labs
10.3.1 Overview
10.3.2 Genetic Diagnostic Labs: Blood Collection Tubes for Liquid Biopsy Market Revenue and Forecast to 2028 (US$ ‘000)
10.4 R&D Centres
10.4.1 Overview
10.4.2 R&D Centres: Blood Collection Tubes for Liquid Biopsy Market Revenue and Forecast to 2028 (US$ ‘000)
10.5 Conventional Diagnostic Centres
10.5.1 Overview
10.5.2 Conventional diagnostic centres: Blood Collection Tubes for Liquid Biopsy Market Revenue and Forecast to 2028 (US$ ‘000)
10.6 Others
10.6.1 Overview
10.6.2 Others: Blood Collection Tubes for Liquid Biopsy Market Revenue and Forecast to 2028 (US$ ‘000)
11. Blood Collection Tubes for Liquid Biopsy Market Revenue and Forecasts to 2028 – North America Analysis
11.1 North America: Blood Collection Tubes for Liquid Biopsy Market
11.1.1 Overview
11.1.2 North America: Blood Collection Tubes for Liquid Biopsy Market – Revenue and Forecast to 2028 (US$ ‘000)
11.1.3 North America: Blood Collection Tubes for Liquid Biopsy Market, by Product- 2019–2028 (US$ ‘000)
11.1.4 North America: Blood Collection Tubes for Liquid Biopsy Market, by Material- 2019–2028 (US$ ‘000)
11.1.5 North America: Blood Collection Tubes for Liquid Biopsy Market, by Application, 2019–2028 (US$ ‘000)
11.1.6 North America: Blood Collection Tubes for Liquid Biopsy Market, by End-User, 2019–2028 (US$ ‘000)
11.1.7 North America: Blood Collection Tubes for Liquid Biopsy Market, by Country, 2021 & 2028 (%)
11.1.7.1 US: Blood Collection Tubes for Liquid Biopsy Market – Revenue and Forecast to 2028 (US$ ‘000)
11.1.7.1.1 Overview
11.1.7.1.2 US: Blood Collection Tubes for Liquid Biopsy Market – Revenue and Forecast to 2028 (US$ ‘000)
11.1.7.1.3 US: Blood Collection Tubes for Liquid Biopsy Market, by Product , 2019–2028 (US$ ‘000)
11.1.7.1.4 US: Blood Collection Tubes for Liquid Biopsy Market, by Material, 2019–2028 (US$ ‘000)
11.1.7.1.5 US: Blood Collection Tubes for Liquid Biopsy Market, by Application, 2019–2028 (US$ ‘000)
11.1.7.1.6 US: Blood Collection Tubes for Liquid Biopsy Market, by End-User, 2019–2028 (US$ ‘000)
11.1.7.2 Canada: Blood Collection Tubes for Liquid Biopsy Market – Revenue and Forecast to 2028 (US$ ‘000)
11.1.7.2.1 Overview
11.1.7.2.2 Canada: Blood Collection Tubes for Liquid Biopsy Market – Revenue and Forecast to 2028 (US$ ‘000)
11.1.7.2.3 Canada: Blood Collection Tubes for Liquid Biopsy Market, by Product- 2019–2028 (US$ ‘000)
11.1.7.2.4 Canada: Blood Collection Tubes for Liquid Biopsy Market, by Material- 2019–2028 (US$ ‘000)
11.1.7.2.5 Canada: Blood Collection Tubes for Liquid Biopsy Market, by Application, 2019–2028 (US$ ‘000)
11.1.7.2.6 Canada: Blood Collection Tubes for Liquid Biopsy Market, by End-User, 2019–2028 (US$ ‘000)
11.1.7.3 Mexico: Blood Collection Tubes for Liquid Biopsy Market – Revenue and Forecast to 2028 (US$ ‘000)
11.1.7.3.1 Overview
11.1.7.3.2 Mexico: Blood Collection Tubes for Liquid Biopsy Market – Revenue and Forecast to 2028 (US$ ‘000)
11.1.7.3.3 Mexico: Blood Collection Tubes for Liquid Biopsy Market, by Product, 2019–2028 (US$ ‘000)
11.1.7.3.4 Mexico: Blood Collection Tubes for Liquid Biopsy Market, by Material, 2019–2028 (US$ ‘000)
11.1.7.3.5 Mexico: Blood Collection Tubes for Liquid Biopsy Market, by Application, 2019–2028 (US$ ‘000)
11.1.7.3.6 Mexico: Blood Collection Tubes for Liquid Biopsy Market, by End-User, 2019–2028 (US$ ‘000)
12. Impact Of COVID-19 Pandemic on Blood Collection Tubes for Liquid Biopsy Market
12.1 North America: Impact Assessment of COVID-19 Pandemic
13. Blood Collection Tubes for Liquid Biopsy Market–Industry Landscape
13.1 Overview
13.2 Organic Developments
13.2.1 Overview
13.3 Inorganic Developments
13.3.1 Overview
14. Company Profiles
14.1 PreAnalytiX GmbH
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 Biocept, Inc.
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 F. HOFFMANN-LA ROCHE LTD.
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 STRECK
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 Norgen Biotek Corp
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 Exact Sciences Corporation
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 Greiner AG
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 MagBio Genomics, Inc
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 Zymo Research Corporation
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments
14.10 Apostle Sciences
14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments
15. Appendix
15.1 About The Insight Partners
15.2 Glossary of Terms
LIST OF TABLES
Table 1. North America Blood Collection Tubes for Liquid Biopsy Market, by Product – Revenue and Forecast to 2028 (US$ ‘000)
Table 2. North America Blood Collection Tubes for Liquid Biopsy Market, by Material – Revenue and Forecast to 2028 (US$ ‘000)
Table 3. North America Blood Collection Tubes for Liquid Biopsy Market, by Application – Revenue and Forecast to 2028 (US$ ‘000)
Table 4. North America Blood Collection Tubes for Liquid Biopsy Market, by End-User – Revenue and Forecast to 2028 (US$ ‘000)
Table 5. US Blood Collection Tubes for Liquid Biopsy Market, by Product – Revenue and Forecast to 2028 (US$ ‘000)
Table 6. US Blood Collection Tubes for Liquid Biopsy Market, by Material – Revenue and Forecast to 2028 (US$ ‘000)
Table 7. US Blood Collection Tubes for Liquid Biopsy Market, by Application – Revenue and Forecast to 2028 (US$ ‘000)
Table 8. US Blood Collection Tubes for Liquid Biopsy Market, by End-User – Revenue and Forecast to 2028 (US$ ‘000)
Table 9. Canada: Blood Collection Tubes for Liquid Biopsy Market, by Product – Revenue and Forecast to 2028 (US$ ‘000)
Table 10. Canada: Blood Collection Tubes for Liquid Biopsy Market, by Material – Revenue and Forecast to 2028 (US$ ‘000)
Table 11. Canada Blood Collection Tubes for Liquid Biopsy Market, by Application – Revenue and Forecast to 2028 (US$ ‘000)
Table 12. Canada Blood Collection Tubes for Liquid Biopsy Market, by End-User – Revenue and Forecast to 2028 (US$ ‘000)
Table 13. Mexico: Blood Collection Tubes for Liquid Biopsy Market, by Product – Revenue and Forecast to 2028 (US$ ‘000)
Table 14. Mexico: Blood Collection Tubes for Liquid Biopsy Market, by Material – Revenue and Forecast to 2028 (US$ ‘000)
Table 15. Mexico Blood Collection Tubes for Liquid Biopsy Market, by Application – Revenue and Forecast to 2028 (US$ ‘000)
Table 16. Mexico Blood Collection Tubes for Liquid Biopsy Market, by End User – Revenue and Forecast to 2028 (US$ ‘000)
Table 17. Organic Developments Done By Companies
Table 18. Inorganic Developments Done By Companies
Table 19. Glossary of Terms
LIST OF FIGURES
Figure 1. Blood Collection Tubes for Liquid Biopsy Market Segmentation
Figure 2. Blood Collection Tubes for Liquid Biopsy Market, By Country
Figure 3. North America Blood Collection Tubes for Liquid Biopsy Market Overview
Figure 4. CcfDNA Tubes Segment Held Largest Share of Product Segment in Blood Collection Tubes for Liquid Biopsy Market
Figure 5. North America Blood Collection Tubes for Liquid Biopsy Market- Leading Country Markets (US$ ‘000)
Figure 6. North America: PEST Analysis
Figure 7. Experts Opinion
Figure 8. North America Blood Collection Tubes for Liquid Biopsy Market– Revenue Forecast and Analysis – 2021 - 2028
Figure 9. Blood Collection Tubes for Liquid Biopsy Market, by Product, 2021 & 2028 (%)
Figure 10. CcfDNA Tubes: Blood Collection Tubes for Liquid Biopsy Market Revenue and Forecasts to 2028 (US$ ‘000)
Figure 11. cfRNA Tubes: Blood Collection Tubes for Liquid Biopsy Market Revenue and Forecasts to 2028 (US$ ‘000)
Figure 12. CTC Tubes: Blood Collection Tubes for Liquid Biopsy Market Revenue and Forecasts to 2028 (US$ ‘000)
Figure 13. gDNA Tubes: Blood Collection Tubes for Liquid Biopsy Market Revenue and Forecasts to 2028 (US$ ‘000)
Figure 14. Intracellular RNA Tubes: Blood Collection Tubes for Liquid Biopsy Market Revenue and Forecasts to 2028 (US$ ‘000)
Figure 15. Others: Blood Collection Tubes for Liquid Biopsy Market Revenue and Forecasts to 2028 (US$ ‘000)
Figure 16. Blood Collection Tubes for Liquid Biopsy Market Share by Material - 2021 & 2028 (%)
Figure 17. Plastic: Blood Collection Tubes for Liquid Biopsy Market Revenue and Forecasts To 2028 (US$ ‘000)
Figure 18. Glass: Blood Collection Tubes for Liquid Biopsy Market Revenue and Forecasts To 2028 (US$ ‘000)
Figure 19. Blood Collection Tubes for Liquid Biopsy Market Share by Application - 2021 & 2028 (%)
Figure 20. In-Vitro Diagnostics (IVD): Blood Collection Tubes for Liquid Biopsy Market Revenue and Forecasts To 2028 (US$ ‘000)
Figure 21. Research: Blood Collection Tubes for Liquid Biopsy Market Revenue and Forecasts To 2028 (US$ ‘000)
Figure 22. Blood Collection Tubes for Liquid Biopsy Market Share by End User - 2021 & 2028 (%)
Figure 23. Genetic Diagnostic Labs: Blood Collection Tubes for Liquid Biopsy Market Revenue and Forecasts To 2028 (US$ ‘000)
Figure 24. R&D centres: Blood Collection Tubes for Liquid Biopsy Market Revenue and Forecasts To 2028 (US$ ‘000)
Figure 25. Conventional diagnostic centres: Blood Collection Tubes for Liquid Biopsy Market Revenue and Forecasts To 2028 (US$ ‘000)
Figure 26. Others: Blood Collection Tubes for Liquid Biopsy Market Revenue and Forecasts To 2028 (US$ ‘000)
Figure 27. North America: Blood Collection Tubes for Liquid Biopsy Market, by Key Country – Revenue (2021) (US$ ‘000)
Figure 28. North America Blood Collection Tubes for Liquid Biopsy Market Revenue and Forecast to 2028 (US$ ‘000)
Figure 29. North America: Blood Collection Tubes for Liquid Biopsy Market, by Country, 2021 & 2028 (%)
Figure 30. US: Blood Collection Tubes for Liquid Biopsy Market – Revenue and Forecast to 2028 (US$ ‘000)
Figure 31. Canada: Blood Collection Tubes for Liquid Biopsy Market – Revenue and Forecast to 2028 (US$ ‘000)
Figure 32. Mexico: Blood Collection Tubes for Liquid Biopsy Market – Revenue and Forecast to 2028 (US$ ‘000)
Figure 33. Impact of COVID-19 Pandemic in North American Country Markets
- Lumenis Be Ltd.
- Ellex Medical Laser (Noval Eye Medical)
- Koninklijke Philips N.V.
- BIOLASE, Inc.
- Boston Scientific Corporation
- Bausch Health Companies Inc.
- Alcon Inc.
- Iridex Corporation
- Candela Medical
- CryoLife, Inc.
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the North America blood collection tubes for liquid biopsy market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the North America blood collection tubes for liquid biopsy market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.